Brighton Jones LLC’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $406K | Buy |
5,185
+805
| +18% | +$63K | 0.01% | 602 |
|
|
2025
Q1 | $317K | Buy |
4,380
+793
| +22% | +$57.5K | 0.01% | 514 |
|
|
2024
Q4 | $266K | Buy |
+3,587
| New | +$266K | 0.01% | 553 |
|
|
2024
Q3 | – | Sell |
-3,742
| Closed | -$346K | – | 610 |
|
|
2024
Q2 | $346K | Buy |
3,742
+339
| +10% | +$31.3K | 0.01% | 440 |
|
|
2024
Q1 | $325K | Buy |
3,403
+222
| +7% | +$21.2K | 0.01% | 441 |
|
|
2023
Q4 | $243K | Sell |
3,181
-25
| -0.8% | -$1.91K | 0.01% | 490 |
|
|
2023
Q3 | $222K | Sell |
3,206
-184
| -5% | -$12.7K | 0.01% | 477 |
|
|
2023
Q2 | $320K | Buy |
3,390
+576
| +20% | +$54.3K | 0.02% | 382 |
|
|
2023
Q1 | $233K | Buy |
+2,814
| New | +$233K | 0.01% | 433 |
|
|
2022
Q4 | – | Sell |
-2,462
| Closed | -$203K | – | 489 |
|
|
2022
Q3 | $203K | Buy |
2,462
+74
| +3% | +$6.1K | 0.01% | 421 |
|
|
2022
Q2 | $227K | Buy |
2,388
+57
| +2% | +$5.42K | 0.01% | 396 |
|
|
2022
Q1 | $274K | Buy |
2,331
+90
| +4% | +$10.6K | 0.01% | 386 |
|
|
2021
Q4 | $290K | Buy |
2,241
+29
| +1% | +$3.75K | 0.01% | 383 |
|
|
2021
Q3 | $250K | Buy |
2,212
+62
| +3% | +$7.01K | 0.01% | 400 |
|
|
2021
Q2 | $223K | Buy |
+2,150
| New | +$223K | 0.01% | 431 |
|
|
2020
Q4 | – | Sell |
-3,039
| Closed | -$243K | – | 403 |
|
|
2020
Q3 | $243K | Buy |
3,039
+63
| +2% | +$5.04K | 0.02% | 284 |
|
|
2020
Q2 | $206K | Sell |
2,976
-282
| -9% | -$19.5K | 0.02% | 274 |
|
|
2020
Q1 | $205K | Buy |
3,258
+24
| +0.7% | +$1.51K | 0.02% | 256 |
|
|
2019
Q4 | $251K | Sell |
3,234
-108
| -3% | -$8.38K | 0.03% | 279 |
|
|
2019
Q3 | $245K | Buy |
+3,342
| New | +$245K | 0.03% | 256 |
|
|
2019
Q2 | – | Sell |
-3,579
| Closed | -$228K | – | 314 |
|
|
2019
Q1 | $228K | Buy |
+3,579
| New | +$228K | 0.03% | 273 |
|